<DOC>
	<DOCNO>NCT00259038</DOCNO>
	<brief_summary>The study evaluate safety efficacy intravenous infusion carperitide use pressure measurement inside heart great vessel measure carperitide concentration blood .</brief_summary>
	<brief_title>Evaluation Effects Carperitide Patients With Congestive Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>Is hospitalize congestive heart failure ( CHF ) Has SwanGanz catheter insert CHF management pulmonary capillary wedge pressure 18 mmHg high Has heart transplant Requires mechanical ventilation mechanical circulatory support</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Carperitide</keyword>
	<keyword>Atrial Natriuretic Peptide</keyword>
	<keyword>Treatment efficacy</keyword>
	<keyword>Safety</keyword>
	<keyword>Heart failure , Congestive</keyword>
	<keyword>Pulmonary Artery Catheterization</keyword>
</DOC>